Cargando…
Blastocystosis in patients with gastrointestinal symptoms: a case–control study
BACKGROUND: Blastocystosis is a frequent bowel disease. We planned to to evaluate the prevalence of Blastocystis spp. in patients who applied to the same internal medicine-gastroenterology clinic with or without gastrointestinal complaints to reveal the association of this parasite with diagnosed IB...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444885/ https://www.ncbi.nlm.nih.gov/pubmed/22963003 http://dx.doi.org/10.1186/1471-230X-12-122 |
_version_ | 1782243731338952704 |
---|---|
author | Cekin, Ayhan Hilmi Cekin, Yesim Adakan, Yesim Tasdemir, Ezel Koclar, Fatma Gulsun Yolcular, Basak Oguz |
author_facet | Cekin, Ayhan Hilmi Cekin, Yesim Adakan, Yesim Tasdemir, Ezel Koclar, Fatma Gulsun Yolcular, Basak Oguz |
author_sort | Cekin, Ayhan Hilmi |
collection | PubMed |
description | BACKGROUND: Blastocystosis is a frequent bowel disease. We planned to to evaluate the prevalence of Blastocystis spp. in patients who applied to the same internal medicine-gastroenterology clinic with or without gastrointestinal complaints to reveal the association of this parasite with diagnosed IBS and IBD. METHODS: A total of 2334 patients with gastrointestinal symptoms composed the study group, which included 335 patients with diagnosed inflammatory bowel disease and 877 with irritable bowel syndrome. Patients without any gastrointestinal symptoms or disease (n = 192) composed the control group. Parasite presence was investigated by applying native-Lugol and formol ethyl acetate concentration to stool specimens, and trichrome staining method in suspicious cases. RESULTS: Blastocystis spp. was detected in 134 patients (5.74%) in the study group and 6 (3.12%) in the control group (p = 0.128). In the study group, Blastocystis spp. was detected at frequencies of 8.7% in ulcerative colitis (24/276), 6.78% in Crohn’s disease (4/59), 5.82% in irritable bowel syndrome (51/877), and 4.9% in the remaining patients with gastrointestinal symptoms (55/1122). Blastocystis spp. was detected at a statistically significant ratio in the inflammatory bowel disease (odds ratio [OR] = 2.824; 95% confidence interval [CI]: 1.149-6.944; p = 0.019) and ulcerative colitis (OR = 2.952; 95% CI: 1.183-7.367; p = 0.016) patients within this group compared to controls. There were no statistically significant differences between the control group and Crohn’s disease or irritable bowel syndrome patients in terms Blastocystis spp. frequency (p = 0.251, p = 0.133). CONCLUSIONS: Blastocystosis was more frequent in patients with inflammatory bowel disease, especially those with ulcerative colitis. Although symptomatic irritable bowel syndrome and Crohn’s disease patients had higher rates of Blastocystis spp. infection, the differences were not significant when compared to controls. |
format | Online Article Text |
id | pubmed-3444885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34448852012-09-19 Blastocystosis in patients with gastrointestinal symptoms: a case–control study Cekin, Ayhan Hilmi Cekin, Yesim Adakan, Yesim Tasdemir, Ezel Koclar, Fatma Gulsun Yolcular, Basak Oguz BMC Gastroenterol Research Article BACKGROUND: Blastocystosis is a frequent bowel disease. We planned to to evaluate the prevalence of Blastocystis spp. in patients who applied to the same internal medicine-gastroenterology clinic with or without gastrointestinal complaints to reveal the association of this parasite with diagnosed IBS and IBD. METHODS: A total of 2334 patients with gastrointestinal symptoms composed the study group, which included 335 patients with diagnosed inflammatory bowel disease and 877 with irritable bowel syndrome. Patients without any gastrointestinal symptoms or disease (n = 192) composed the control group. Parasite presence was investigated by applying native-Lugol and formol ethyl acetate concentration to stool specimens, and trichrome staining method in suspicious cases. RESULTS: Blastocystis spp. was detected in 134 patients (5.74%) in the study group and 6 (3.12%) in the control group (p = 0.128). In the study group, Blastocystis spp. was detected at frequencies of 8.7% in ulcerative colitis (24/276), 6.78% in Crohn’s disease (4/59), 5.82% in irritable bowel syndrome (51/877), and 4.9% in the remaining patients with gastrointestinal symptoms (55/1122). Blastocystis spp. was detected at a statistically significant ratio in the inflammatory bowel disease (odds ratio [OR] = 2.824; 95% confidence interval [CI]: 1.149-6.944; p = 0.019) and ulcerative colitis (OR = 2.952; 95% CI: 1.183-7.367; p = 0.016) patients within this group compared to controls. There were no statistically significant differences between the control group and Crohn’s disease or irritable bowel syndrome patients in terms Blastocystis spp. frequency (p = 0.251, p = 0.133). CONCLUSIONS: Blastocystosis was more frequent in patients with inflammatory bowel disease, especially those with ulcerative colitis. Although symptomatic irritable bowel syndrome and Crohn’s disease patients had higher rates of Blastocystis spp. infection, the differences were not significant when compared to controls. BioMed Central 2012-09-10 /pmc/articles/PMC3444885/ /pubmed/22963003 http://dx.doi.org/10.1186/1471-230X-12-122 Text en Copyright ©2012 Cekin et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Cekin, Ayhan Hilmi Cekin, Yesim Adakan, Yesim Tasdemir, Ezel Koclar, Fatma Gulsun Yolcular, Basak Oguz Blastocystosis in patients with gastrointestinal symptoms: a case–control study |
title | Blastocystosis in patients with gastrointestinal symptoms: a case–control study |
title_full | Blastocystosis in patients with gastrointestinal symptoms: a case–control study |
title_fullStr | Blastocystosis in patients with gastrointestinal symptoms: a case–control study |
title_full_unstemmed | Blastocystosis in patients with gastrointestinal symptoms: a case–control study |
title_short | Blastocystosis in patients with gastrointestinal symptoms: a case–control study |
title_sort | blastocystosis in patients with gastrointestinal symptoms: a case–control study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444885/ https://www.ncbi.nlm.nih.gov/pubmed/22963003 http://dx.doi.org/10.1186/1471-230X-12-122 |
work_keys_str_mv | AT cekinayhanhilmi blastocystosisinpatientswithgastrointestinalsymptomsacasecontrolstudy AT cekinyesim blastocystosisinpatientswithgastrointestinalsymptomsacasecontrolstudy AT adakanyesim blastocystosisinpatientswithgastrointestinalsymptomsacasecontrolstudy AT tasdemirezel blastocystosisinpatientswithgastrointestinalsymptomsacasecontrolstudy AT koclarfatmagulsun blastocystosisinpatientswithgastrointestinalsymptomsacasecontrolstudy AT yolcularbasakoguz blastocystosisinpatientswithgastrointestinalsymptomsacasecontrolstudy |